@TigerGPT any good news on $To-To The Moon - Tiger Brokers Online Investing Community - To The Moon

@TigerGPT any good news on $Tonix Pharmaceuticals(TNXP)$

@Boybabyrage：$Tonix Pharmaceuticals(TNXP)$ Once the vaccine gets FDA approval, it will be skyrocket

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

TigerGPT
12-02
TigerGPT
Yes, there are some good news articles about Tonix Pharmaceuticals (TNXP). Here are a few of them:
Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects: Tonix Pharmaceuticals presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, highlighting the effects of TNX-102 SL.

Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801: Tonix Pharmaceuticals announced the publication of a paper on the tolerability of TNX-801, a vaccine candidate.

Tonix Pharmaceuticals announces peer-reviewed publication in Msphere Journal: Tonix Pharmaceuticals announced a peer-reviewed publication in Msphere Journal, highlighting the tolerability of TNX-801 in immune-compromised animals.

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30: Tonix Pharmaceuticals reported quarterly losses that beat analyst consensus estimates.

These articles provide insights into the company's research, publications, and financial performance. For more detailed information, you can click on the provided links.
Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it is essential to conduct thorough research and analysis before making any investment decisions.
Let me know if there's anything else I can assist you with!

Leave a comment

1

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":377279086330208,"tweetId":"377279086330208","gmtCreate":1733148304193,"gmtModify":1733148308632,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"authorIdStr":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.79%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/U/4141429963588842\"> @TigerGPT </a>any good news on <a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/U/4141429963588842\"> @TigerGPT </a>any good news on <a href=\"https://ttm.financial/S/TNXP\"> $Tonix Pharmaceuticals(TNXP)$ </a></body></html>","text":"@TigerGPT any good news on $Tonix Pharmaceuticals(TNXP)$","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/377279086330208","repostId":373183558132104,"repostType":1,"repost":{"magic":2,"id":373183558132104,"tweetId":"373183558132104","gmtCreate":1732154753974,"gmtModify":1732154758098,"author":{"id":4178332581629092,"idStr":"4178332581629092","authorId":4178332581629092,"authorIdStr":"4178332581629092","name":"Boybabyrage","avatar":"https://community-static.tradeup.com/news/5b59a07cca9804884b312ca8a7ac871d","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":8,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.11","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":32,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> Once the vaccine gets FDA approval, it will be skyrocket&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v> Once the vaccine gets FDA approval, it will be skyrocket&nbsp;</p></body></html>","text":"$Tonix Pharmaceuticals(TNXP)$ Once the vaccine gets FDA approval, it will be skyrocket","highlighted":1,"essential":1,"paper":1,"link":"https://ttm.financial/post/373183558132104","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["TNXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":75,"xxTargetLangEnum":"ORIG"},"isVote":1,"tweetType":1,"viewCount":272,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TNXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":50,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":377323452018752,"commentId":"377323452018752","gmtCreate":1733148315222,"gmtModify":1733149931022,"authorId":4141429963588842,"author":{"id":4141429963588842,"idStr":"4141429963588842","authorId":4141429963588842,"name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":377279086330208,"objectIdStr":"377279086330208","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"<p>Yes, there are some good news articles about Tonix Pharmaceuticals (TNXP). Here are a few of them:</p><p></p><p><a href=\"https://ttm.financial/NW/2484621444\">Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects</a>: Tonix Pharmaceuticals presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, highlighting the effects of TNX-102 SL.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483862348\">Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801</a>: Tonix Pharmaceuticals announced the publication of a paper on the tolerability of TNX-801, a vaccine candidate.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483674885\">Tonix Pharmaceuticals announces peer-reviewed publication in Msphere Journal</a>: Tonix Pharmaceuticals announced a peer-reviewed publication in Msphere Journal, highlighting the tolerability of TNX-801 in immune-compromised animals.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2482682084\">Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30</a>: Tonix Pharmaceuticals reported quarterly losses that beat analyst consensus estimates.</p>&nbsp;&nbsp;<p></p><p>These articles provide insights into the company's research, publications, and financial performance. For more detailed information, you can click on the provided links.</p><p>Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it is essential to conduct thorough research and analysis before making any investment decisions.</p><p>Let me know if there's anything else I can assist you with!</p>","text":"<p>Yes, there are some good news articles about Tonix Pharmaceuticals (TNXP). Here are a few of them:</p><p></p><p><a href=\"https://ttm.financial/NW/2484621444\">Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects</a>: Tonix Pharmaceuticals presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, highlighting the effects of TNX-102 SL.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483862348\">Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801</a>: Tonix Pharmaceuticals announced the publication of a paper on the tolerability of TNX-801, a vaccine candidate.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483674885\">Tonix Pharmaceuticals announces peer-reviewed publication in Msphere Journal</a>: Tonix Pharmaceuticals announced a peer-reviewed publication in Msphere Journal, highlighting the tolerability of TNX-801 in immune-compromised animals.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2482682084\">Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30</a>: Tonix Pharmaceuticals reported quarterly losses that beat analyst consensus estimates.</p>&nbsp;&nbsp;<p></p><p>These articles provide insights into the company's research, publications, and financial performance. For more detailed information, you can click on the provided links.</p><p>Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it is essential to conduct thorough research and analysis before making any investment decisions.</p><p>Let me know if there's anything else I can assist you with!</p>","html":"<p>Yes, there are some good news articles about Tonix Pharmaceuticals (TNXP). Here are a few of them:</p><p></p><p><a href=\"https://ttm.financial/NW/2484621444\">Tonix Pharmaceuticals presents data, analyses of TNX-102 SL effects</a>: Tonix Pharmaceuticals presented data in a poster presentation at the ACR Convergence 2024 Annual Meeting, highlighting the effects of TNX-102 SL.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483862348\">Tonix Pharmaceuticals announces publication of study on tolerability of TNX-801</a>: Tonix Pharmaceuticals announced the publication of a paper on the tolerability of TNX-801, a vaccine candidate.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2483674885\">Tonix Pharmaceuticals announces peer-reviewed publication in Msphere Journal</a>: Tonix Pharmaceuticals announced a peer-reviewed publication in Msphere Journal, highlighting the tolerability of TNX-801 in immune-compromised animals.</p>&nbsp;&nbsp;<p></p><p></p><p><a href=\"https://ttm.financial/NW/2482682084\">Tonix Pharmaceuticals Holding Corp reports results for the quarter ended September 30</a>: Tonix Pharmaceuticals reported quarterly losses that beat analyst consensus estimates.</p>&nbsp;&nbsp;<p></p><p>These articles provide insights into the company's research, publications, and financial performance. For more detailed information, you can click on the provided links.</p><p>Please note that the information provided is for reference purposes only and does not constitute investment advice. Investing in stocks involves risks, and it is essential to conduct thorough research and analysis before making any investment decisions.</p><p>Let me know if there's anything else I can assist you with!</p>","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/377279086330208"}